These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32963540)

  • 1. Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection.
    Mishra VN; Kumari N; Pathak A; Chaturvedi RK; Gupta AK; Chaurasia RN
    Int J Microbiol; 2020; 2020():8844963. PubMed ID: 32963540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2.
    Shahin K; Zhang L; Mehraban MH; Collard JM; Hedayatkhah A; Mansoorianfar M; Soleimani-Delfan A; Wang R
    Microb Pathog; 2022 Mar; 164():105442. PubMed ID: 35151823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
    Sharma A; Tiwari S; Deb MK; Marty JL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
    Abd El-Aziz TM; Stockand JD
    Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview of Antiviral Properties of Bacteriophages with Emphasis on the Treatment of COVID-19 Infection.
    Jalili M; Ansari N; Pourhossein B; Fazeli M; Jalilian FA
    Infect Disord Drug Targets; 2022; 22(6):e240122200472. PubMed ID: 35068397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophages Could Be a Potential Game Changer in the Trajectory of Coronavirus Disease (COVID-19).
    Wojewodzic MW
    Phage (New Rochelle); 2020 Jun; 1(2):60-65. PubMed ID: 36147892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection.
    Vittoria BL; Imbesi C; Irene G; Calì G; Bitto A
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34070359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses.
    Majid S; Farooq R; Khan MS; Rashid S; Bhat SA; Wani HA; Qureshi W
    SN Compr Clin Med; 2020; 2(10):1767-1776. PubMed ID: 32864575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.
    Yan Y; Shin WI; Pang YX; Meng Y; Lai J; You C; Zhao H; Lester E; Wu T; Pang CH
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32235575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
    Lin L; Lu L; Cao W; Li T
    Emerg Microbes Infect; 2020 Dec; 9(1):727-732. PubMed ID: 32196410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
    Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).
    Park SE
    Clin Exp Pediatr; 2020 Apr; 63(4):119-124. PubMed ID: 32252141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.